“Patients are giving us their data, and we need to honor that by doing something that advances their disease, their cause, their power in the world.”– Jamie Heywood
This week marks the fourth and final installment of our latest video series, which explores what the recent changes at PatientsLikeMe mean for you as well as the entire medical establishment.(Missed the first three interviews?Catch up on what PatientsLikeMe executives Ben Heywood, David S. Williams III and Paul Wicks had to say.)
In today’s video, PatientsLikeMe Co-Founder and Chairman Jamie Heywood talks about the next steps in realizing the goal of PatientsLikeMe:to help all patients determine how they can affect their health outcomes and live the longest, most productive lives possible.What will it take to do that?Tune in to hear his vision of how healthcare could evolve as quickly as technology, provided that the concept of shared data is fully embraced.
“I think what’s really exciting is the scale we’re operating under. My PhD was conducted with 80 patients. Last week, I got survey responses from 4,000 patients in a week. That is unparalleled power in the research world.” – Paul Wicks, PhD
This week marks the third installment of our latest video series, which explores what the recent changes at PatientsLikeMe mean for you as well as the entire medical establishment. (Missed the first two installments? Catch up on what PatientsLikeMe executives Ben Heywood and David S. Williams III had to say.)
In today’s video, PatientsLikeMe R&D Director Paul Wicks shares his thoughts on how the increased scale of PatientsLikeMe will impact not only the types of patient tools we develop moving forward but also the way medical research is conducted. Tune in to hear some highlights of how PatientsLikeMe research efforts are already helping patients and researchers better understand what causes certain diseases.
Stay tuned for the fourth and final installment of our video series next week. To keep up with all PatientsLikeMe videos, subscribe to our YouTube channel today.